The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease:: Phenotype in monozygotic twins

被引:18
|
作者
Munhoz, Renato P. [1 ]
Wakutani, Yosuke [2 ]
Marras, Connie [3 ]
Teive, Helio A. [1 ]
Raskin, Salmo [4 ]
Werneck, Lineu C. [1 ]
Moreno, Danielle [2 ]
Sato, Christine [2 ]
Lang, Anthony E. [3 ,5 ]
Rogaeva, Ekaterina [2 ,5 ]
机构
[1] Univ Fed Parana, Hosp Clin, Neurol Serv, Movement Disorders Unit, Curitiba, Parana, Brazil
[2] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[3] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON, Canada
[4] Genet Lab, Curitiba, Parana, Brazil
[5] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
mutation; Parkinson's disease; G2919S; LRRK; Brazil;
D O I
10.1002/mds.21832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the Leucine-Rich Repeat Kinase 2 gene (LRRK2) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of LRRK2 kindreds demonstrate an extremely variable age-at-onset in affected members of the same family. The G2019S is the most common LRRK2 mutation, which accounts for 1-5% PD patients in North America, and up to 40% of patients from an isolated Arab population. We assessed the frequency of the G2019S mutation in 83 Brazilian PD patients originally preselected for having an early age-at-onset (< 50 years) and/or a positive family history. The mutation was detected in three probands (3.5%). Our clinical findings in these kindreds include the first description of the phenotype in identical twins discordant for handedness (a general phenomenon found in similar to 25% monozygotic twins). However, both twins developed right asymmetric PD. The clinical presentation of twins was strikingly similar including an identical PD onset at age 60. This observation may suggest that genetic factors predominantly determine age-at-onset. (C) 2007 Movement Disorder Society.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [41] Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries
    Bar-Shira, Anat
    Hutter, Carolyn M.
    Giladi, Nir
    Zabetian, Cyrus P.
    Orr-Urtreger, Avi
    NEUROGENETICS, 2009, 10 (04) : 355 - 358
  • [42] Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
    Jackson, Lauren M.
    Woodruff, Bryan K.
    Tremblay, Cecilia
    Shill, Holly A.
    Beach, Thomas G.
    Serrano, Geidy E.
    Adler, Charles H.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (07): : 874 - 878
  • [43] Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson's disease
    Soto, Marta
    Fernandez, Manel
    Bravo, Paloma
    Lahoz, Sara
    Garrido, Alicia
    Sanchez-Rodriguez, Antonio
    Rivera-Sanchez, Maria
    Sierra, Maria
    Melon, Paula
    Roig-Garcia, Ana
    Naito, Anna
    Casey, Bradford
    Camps, Jordi
    Tolosa, Eduardo
    Marti, Maria-Jose
    Infante, Jon
    Ezquerra, Mario
    Fernandez-Santiago, Ruben
    NPJ PARKINSONS DISEASE, 2023, 9 (01)
  • [44] Ashkenazi Parkinson’s disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries
    Anat Bar-Shira
    Carolyn M. Hutter
    Nir Giladi
    Cyrus P. Zabetian
    Avi Orr-Urtreger
    neurogenetics, 2009, 10 : 355 - 358
  • [45] THE ABSENCE OF THE COMMON LRRK2 G2019S MUTATION IN 120 YOUNG ONSET HUNGARIAN PARKINON'S DISEASE PATIENTS
    Balicza Peter
    Bereznai Benjamin
    Takats Annamaria
    Klivenyi Peter
    Dibo Gyoergy
    Hidasi Eszter
    Balogh Istvan
    Molnar Maria Judit
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (7-8): : 239 - 242
  • [46] Multiple sclerosis in LRRK2 G2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrier
    Wise, Adina
    Ortega, Roberto A.
    Raymond, Deborah
    Cervera, Alessandra
    Thorn, Emma
    Leaver, Katherine
    Russell, David S.
    Bressman, Susan B.
    Crary, John F.
    Saunders-Pullman, Rachel
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [47] Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
    Leaver, Katherine
    Viser, Aaron
    Kopell, Brian H.
    Ortega, Roberto A.
    Miravite, Joan
    Okun, Michael S.
    Elango, Sonya
    Raymond, Deborah
    Bressman, Susan B.
    Saunders-Pullman, Rachel
    San Luciano, Marta
    JOURNAL OF NEUROSURGERY, 2022, 137 (01) : 184 - 191
  • [48] Prevalence of Cancer in Parkinson's Disease Related to R1441G and G2019S Mutations in LRRK2
    Ruiz-Martinez, Javier
    de la Riva, Patricia
    Rodriguez-Oroz, Maria C.
    Mondragon Rezola, Elisabet
    Bergareche, Alberto
    Gorostidi, Ana
    Gago, Belen
    Estanga, Ainara
    Larranaga, Nerea
    Sarasqueta, Cristina
    Lopez de Munain, Adolfo
    Marti Masso, Jose F.
    MOVEMENT DISORDERS, 2014, 29 (06) : 750 - 755
  • [49] LRRK2 G2019S in the North African Population: A Review
    Benamer, Hani T. S.
    de Silva, Rajith
    EUROPEAN NEUROLOGY, 2010, 63 (06) : 321 - 325
  • [50] Is the G2019S LRRK2 mutation common in all southern European populations?
    Papapetropoulos, Spiridon
    Adi, Nikhil
    Shehadeh, Lina
    Bishopric, Nanette
    Singer, Carlos
    Argyriou, Andreas A.
    Chroni, Elizabeth
    JOURNAL OF CLINICAL NEUROSCIENCE, 2008, 15 (09) : 1027 - 1030